Kamdem, LK; Meineke, I; Gödtel-Armbrust, U et al.
Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1.Chem Res Toxicol. Bd. 19. H. 4. 2006 S. 577-86
Förstermann, U; Münzel, T
Endothelial nitric oxide synthase in vascular disease: from marvel to menace.Circulation. Bd. 113. H. 13. 2006 S. 1708-14
Geber, C; Mang, CF; Kilbinger, H
Facilitation and inhibition by capsaicin of cholinergic neurotransmission in the guinea-pig small intestine.Naunyn Schmiedebergs Arch Pharmacol. Bd. 372. H. 4. 2006 S. 277-83
Schirmer, M; Toliat, MR; Haberl, M et al.
Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations.Pharmacogenet Genomics. Bd. 16. H. 1. 2006 S. 59-71
Lang, T; Haberl, M; Jung, D et al.
Genetic variability, haplotype structures, and ethnical diversity of hepatic transporters MDR3 (ABCB4) and BSEP (ABCB11).Drug Metab Dispos. Bd. 34. H. 9. 2006 S. 1582-1599
Martin, L; Comalada, M; Marti, L et al.
Granulocyte-macrophage colony-stimulating factor increases L-arginine transport through the induction of CAT2 in bone marrow-derived macrophages.Am J Physiol Cell Physiol. Bd. 290. H. 5. 2006 S. C1364-72
Gerber, S; Krasky, A; Rohwer, A et al.
Identification and characterisation of the dopamine receptor II from the cat flea Ctenocephalides felis (CfDopRII).Insect Biochem Mol Biol. Bd. 36. H. 10. 2006 S. 749-58
Schlereth, T; Birklein, F; an Haack, K et al.
In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin.Br J Pharmacol. Bd. 147. H. 2. 2006 S. 183-7
Förstermann, U
Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal.Biol Chem. Bd. 387. H. 12. 2006 S. 1521-33
Köhler, SC; Von Ahsen, N; Schlumbohm, C et al.
Marmoset CYP3A21, a model for human CYP3A4: protein expression and functional characterization of the promoter.Xenobiotica. Bd. 36. H. 12. 2006 S. 1210-26